Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Change in Cash (2020 - 2025)

Historic Change in Cash for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to -$2.2 million.

  • NeuroPace's Change in Cash fell 18581.97% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 826.17%. This contributed to the annual value of -$4.6 million for FY2024, which is 14040.86% down from last year.
  • According to the latest figures from Q3 2025, NeuroPace's Change in Cash is -$2.2 million, which was down 18581.97% from -$4.2 million recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Change in Cash ranged from a high of $17.2 million in Q2 2021 and a low of -$12.5 million during Q1 2021
  • For the 5-year period, NeuroPace's Change in Cash averaged around -$315052.6, with its median value being -$154000.0 (2024).
  • Per our database at Business Quant, NeuroPace's Change in Cash soared by 1340000.0% in 2023 and then crashed by 450000.0% in 2024.
  • NeuroPace's Change in Cash (Quarter) stood at -$7.4 million in 2021, then soared by 112.32% to $917000.0 in 2022, then surged by 809.6% to $8.3 million in 2023, then crashed by 123.83% to -$2.0 million in 2024, then fell by 11.12% to -$2.2 million in 2025.
  • Its last three reported values are -$2.2 million in Q3 2025, -$4.2 million for Q2 2025, and $13.6 million during Q1 2025.